RESUMO
Background: Mesenchymal stem cells (MSCs) are multipotent precursor cells with the ability to self-renew and differentiate into multiple cell linage, including the Schwann-like fate that promotes regeneration after lesion. Raman spectroscopy provides a precise characterization of the osteogenic, adipogenic, hepatogenic and myogenic differentiation of MSCs. However, the differentiation of bone marrow mesenchymal stem cells (BMSCs) towards a glial phenotype (Schwann-like cells) has not been characterized before using Raman spectroscopy. Method: We evaluated three conditions: 1) cell culture from rat bone marrow undifferentiated (uBMSCs), and two conditions of differentiation; 2) cells exposed to olfactory ensheathing cells-conditioned medium (dBMSCs) and 3) cells obtained from olfactory bulb (OECs). uBMSCs phenotyping was confirmed by morphology, immunocytochemistry and flow cytometry using antibodies of cell surface: CD90 and CD73. Glial phenotype of dBMSCs and OECs were verified by morphology and immunocytochemistry using markers of Schwann-like cells and OECs such as GFAP, p75 NTR and O4. Then, the Principal Component Analysis (PCA) of Raman spectroscopy was performed to discriminate components from the high wavenumber region between undifferentiated and glial-differentiated cells. Raman bands at the fingerprint region also were used to analyze the differentiation between conditions. Results: Differences between Raman spectra from uBMSC and glial phenotype groups were noted at multiple Raman shift values. A significant decrease in the concentration of all major cellular components, including nucleic acids, proteins, and lipids were found in the glial phenotype groups. PCA analysis confirmed that the highest spectral variations between groups came from the high wavenumber region observed in undifferentiated cells and contributed with the discrimination between glial phenotype groups. Conclusion: These findings support the use of Raman spectroscopy for the characterization of uBMSCs and its differentiation in the glial phenotype.
RESUMO
Glyphosate is a broad-spectrum, non-selective herbicide used to control weeds and protect agricultural crops, and it is classified as potentially carcinogenic by the International Agency for Research on Cancer. In Mexico, the use of pesticides is a common practice, including glyphosate. However, on December 31st, 2020, the Mexican government decreed the prohibition of this herbicide as of January 2024. In this review, we investigate the association between glyphosate and cancer risk and found that most of the studies focused using animals showing negative effects such as genotoxicity, cytotoxicity and neurotoxicity, some studies used cancer cell lines showing proliferative effects due to glyphosate exposure. To our knowledge, in Mexico, there are no scientific reports on the association of glyphosate with any type of cancer. In addition, we reviewed the toxicological effects of the herbicide glyphosate, and the specific case of the current situation of the use and environmental damage of this herbicide in Mexico. We found that few studies have been published on glyphosate, and that the largest number of publications are from the International Agency for Research on Cancer classification to date. Additionally, we provide data on glyphosate stimulation at low doses as a biostimulant in crops and analytical monitoring techniques for the detection of glyphosates in different matrices. Finally, we have tried to summarize the actions of the Mexican government to seek sustainable alternatives and replace the use of glyphosate, to obtain food free of this herbicide and take care of the health of the population and the environment.
